Showing results (321-330 of 2,812) with videos related to
Sort By:
Pageof 282
Diabetes Technology & Therapeutics|April 18, 2018
Evaluation of Four Blood Glucose Monitoring Systems for Self-Testing with Built-in Insulin Dose Advisor Based on ISO 15197:2013: System Accuracy and Hematocrit InfluenceNina Jendrike, Annette Baumstark, Stefan Pleus, et al.Diabetes Technology & Therapeutics|May 31, 2018
Optimization of Insulin Regimen and Glucose Outcomes with Short-Term Real-Time Continuous Glucose Monitoring in Adult Type 1 Diabetes Patients with Suboptimal Control on Multiple Daily Injections: The Adult DIACCOR StudySylvie Picard, Hélène Hanaire, Yves Reznik, et al.Diabetes Technology & Therapeutics|May 23, 2009
Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedlesJyoti Gupta, Eric I Felner, Mark R PrausnitzDiabetes Technology & Therapeutics|May 23, 2009
Reduced daily risk of glycemic variability: comparison of exenatide with insulin glargineAnthony L McCall, Daniel J Cox, Robert Brodows, et al.Diabetes Technology & Therapeutics|May 23, 2009
Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidaseDaniel E Vaughn, Richard C Yocum, Douglas B Muchmore, et al.Diabetes Technology & Therapeutics|May 23, 2009
The use of an isometric handgrip test to show autonomic damage in people with diabetesJerrold Petrofsky, Michelle Prowse, Wilton Remigio, et al.Diabetes Technology & Therapeutics|May 23, 2009
Competact, a fixed combination of pioglitazone and metformin, improves metabolic markers in type 2 diabetes patients with insufficient glycemic control by metformin alone--results from a post-marketing surveillance trial under daily routine conditionsThomas Schöndorf, Efstrathios Karagiannis, Richard E K Posseldt, et al.Diabetes Technology & Therapeutics|May 23, 2009
Type 2 diabetes increases risk for obesity among subsequent generationsDeepti Chathurvedi, Rajesh Khadgawat, Bindu Kulshrestha, et al.Diabetes Technology & Therapeutics|May 28, 2009
The chemistry of commercial continuous glucose monitorsGeoffrey McGarraughDiabetes Technology & Therapeutics|May 28, 2009
Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic controlDavid RodbardPageof 282